Publication: IFN-gamma stimulation of dental follicle mesenchymal stem cells modulates immune response of CD4(+) T lymphocytes in Der p1(+) asthmatic patients in vitro
No Thumbnail Available
Date
2019
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
ELSEVIER ESPANA SLU
Abstract
Background: House dust mite (Dermataphagoides pteronyssinus) is a widespread risk factor in the development of asthma. CD4(+) T lymphocytes have an important role in the pathogenesis of allergic asthma by polarizing to Th2 cells. Objective: We aimed to evaluate the immunoregulatory effects of dental follicle mesenchymal stem cells with and without IFN-gamma stimulation on peripheral blood mononuclear cells of house dust mite sensitive asthmatic patients, and compared those with Dexamethasone as a systemic steroid. Material and methods: PBMC of asthmatic patients and healthy individuals separately cultured with or without DF-MSCs in the presence and absence of IFN-gamma or Der p1 or Dexamethasone for 72 h. CD4(+) T proliferation, cell viability, CD4(+)CD25(+)FoxP3(+) Treg cell frequency and cytokine profiles of PBMC were evaluated via flow cytometry. Results: DF-MSCs suppressed proliferation of CD4(+) T lymphocytes (p(CDmix) < 0.01, p(Derp1) < 0.01, p(IFN) < 0.005) by increasing the number of FoxP3 expressing CD4(+)CD25(+) T regulatory cells (p(CDmix) < 0.005, p(Derp1) < 0.01, p(IFN) < 0.001) and suppressed lymphocyte apoptosis (p(CDmix) < 0.05, p(Derp1) < 0.05, p(IFN) < 0.05), while Dexamethasone increased the apoptosis and decreased Treg cell frequency in asthmatic patients. IFN-gamma stimulation increased the suppressive effect of DF-MSCs and also enhanced the frequency of FoxP3 expressing CD4(+)CD25(+) T regulatory cells. The cytokine levels were regulated by DF-MSCs by reducing IL-4 cytokine levels (p(CDmix) < 0.01, p(Derp1) < 0.05, p(IFN) < 0.05) and upregulating IFN-gamma levels (p(CDmix) < 0.01, p(Derp1) < 0.05, p(IFN) < 0.005) in asthmatic patients. Conclusion: IFN-gamma stimulated DF-MSCs were found to have a high modulatory effect on CD4(+) T cell responses, while Dexamethasone had an apoptotic effect on CD4(+) T cells in asthmatic patients. DF-MSCs may be a new cell-based therapy option for allergic diseases including asthma. (C) 2019 SEICAP. Published by Elsevier Espana, S.L.U. All rights reserved.
Description
Keywords
Dental follicle mesenchymal stem cells, Asthma, House dust mite, Der p1, INTERFERON-GAMMA, COCKROACH ALLERGEN, INFLAMMATION, EPITHELIUM, PATHOLOGY, EXPOSURE, CHILDREN